Rajan Gogna

Dr. Rajan Gogna, an eminent cancer biologist and assistant professor, currently stands at the helm of Fitness Fingerprint Therapeutics as its Founder and CEO. His remarkable journey in the field of cancer biology is highlighted by his association with Virginia Commonwealth University (VCU) School of Medicine, where he significantly contributes as an assistant professor.

Dr. Gogna's academic credentials are noteworthy, featuring a Ph.D., MS, and MBA, demonstrating his wide-ranging expertise in both the scientific and managerial aspects of biotechnology and cancer research. His prominent role as the Lab Head of the Cell Competition and Fitness Laboratory and Co-Director of the Tumor Microenvironment Program at VIMM underscores his dedication to cancer research.

In 2019, Dr. Gogna's groundbreaking work, which proposed innovative methods to make tumors more susceptible to chemotherapy, was published in the prestigious journal "Nature". This research identified a new mechanism for cancer cell growth, specifically focusing on how cancer cells can influence the cells around them. Dr. Gogna's research has been integral in understanding the "fitness fingerprints" of human cells and their role in competitive growth in cancer. His studies delve into the molecular mechanisms that allow human cells to assess and compare fitness, which is crucial for understanding cancer progression and developing therapeutic strategies.

Dr. Gogna’s approach to research is characterized by using cutting-edge technologies to explore the clinical and therapeutic potential of cell competition and fitness pathways in human diseases. His vision for Fitness Fingerprint Therapeutics revolves around leveraging these insights to develop more personalized and effective cancer treatments.